The 1st AOP Community of Practice Symposium

      Date
      Feb 15, 2022 - Feb 22, 2022
      Location
      Virtual

      The 1st AOP Community of Practice Symposium focuses on topics around Adverse Outcome Pathways (AOPs) which are a conceptual framework for portraying scientifically credible, causal, linkages between perturbations of biological systems at the molecular, cellular, biochemical levels of organization and resulting adverse effects to human health or the environment. They are a knowledge synthesis and aggregation tool with a wide range of applications in environmental safety assessments of chemicals and radiation, environmental health and human medicine, life sciences research, and a range of regulatory and policy arenas that rely on science-based decision-making. The sessions are open to all and will be held entirely on zoom.

      Go to the conference website: https://virtual.oxfordabstracts.com/#/event/2637/program

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.